What is Polaryx Therapeutics, Inc. 's common stock?

Polaryx Therapeutics, Inc. (PLYX) reported common stock of $560M in Q4 2025.

What does common stock mean?

The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).

Principal Financial GroupPFG

$5M0.0%

Deckers Outdoor CorporationDECK

$1.4M-6.8%

GlaukosGKOS

$58K+1.8%

GE HealthCare TechnologiesGEHC

$5M0.0%

Allegro MicroSystems, Inc.ALGM

$1.85M+0.6%

Veeva SystemsVEEV

$2K0.0%

Operating income-$2.0M+61.2%

Net income-$2.5M+49.6%

EPS (diluted)-$0.05+54.5%

Cash & equivalents$3.1M+1,132%

Total equity$2.5M-41.5%

Total assets$3.5M—

Operating cash flow-$2.1M-191%

Market cap$115.64M—

Return on equity-1,209.8%—

Current ratio3.5×—

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Polaryx Therapeutics, Inc. ’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Polaryx Therapeutics, Inc. 's common stock?: Polaryx Therapeutics, Inc. (PLYX) reported common stock of $560M in Q4 2025.
What does common stock mean?: The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).